HIGHLIGHTS
- who: Anticoagulation and colleagues from the National Institute for Health and Care ExcellenceRCT have published the paper: REVIEW Open Access, in the Journal: (JOURNAL)
SUMMARY
The incidence of first VTE was an alarming 54-fold higher (5,800 vs. 107 per 100,000 person-years) in patients with active cancer compared to those without cancer in a UK population-based study. Following an index VTE, patients with malignancy have a 3-fold higher risk of VTE recurrence than patients without cancer, even when receiving anticoagulation. An American population-based study following incident VTE . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.